Hi-Tech Pharmacal Announces $25M Settlement Regarding Texas Pricing Investigation

By: Benzinga
Hi-Tech Pharmacal (NASDAQ: HITK ) today announced that the Texas Attorney General has agreed to close its investigation of Hi-Tech's pricing of products that were purchased with Texas Medicaid dollars. In
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.